On April 8, 2024, Seres Therapeutics, Inc announced that it has held its annual general meeting of shareholders on April 4, 2024, and declared voting results. Accordingly, a stockholder proposal on simple majority vote from Kenneth Steiner was approved by the shareholders of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.08 USD | +9.02% | +48.05% | -22.86% |
Apr. 26 | Foreign automakers eager for Chinese partners at Beijing auto show | RE |
Apr. 25 | Battle for 'tech luxury' in China as EVs get smarter - and cheaper | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.86% | 150M | |
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.
- Declaration of Voting Results by Seres Therapeutics